12:00 AM
Jun 29, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Compugen preclinical data

In a mouse model of IBD, CGEN-25007 led to an increase in survival rate and reversal of weight loss, while mice treated with a...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >